Igene Biotechnology, Inc.
IGNE
Rank in Stocks
#34347
Igene Biotechnology, Inc. is dedicated to the discovery, development,... Igene Biotechnology, Inc. is dedicated to the discovery, development, production, and commercialization of specialized ingredients for both human and animal nutrition. A key offering from the company is natural astaxanthin, a valuable nutrient utilized as a coloring agent for farmed salmon and trout. Additionally, it supplies a variety of ingredients and finished products to the nutraceutical and animal feed sectors. The company also extends its expertise through research and development services, which include enhancing microbial strains and skillfully developing and scaling up fermentation processes β from initial lab-based shake flasks to pilot plants and ultimately, commercial-sized fermentors. Furthermore, Igene provides analytical chemistry services for accurately identifying and quantifying carotenoids in food, feed, and animal tissues, notably offering verification to distinguish between wild and farm-raised salmonids. Established in 1981 and based in Columbia, Maryland, the company was originally named IGI Biotechnology, Inc. before officially adopting the name IGENE Biotechnology, Inc. in April 1986.
Share Price
$0.00001
Last synced: 2026-11-09
Market Cap
$15.65K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Igene Biotechnology, Inc. (IGNE)
Category
Basic Materials
EPS for Igene Biotechnology, Inc. (IGNE)
EPS as of September 2010 TTM: $0.00
According to Igene Biotechnology, Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2009 the company had an EPS of 0.00, an increase over its 2008 EPS of $-0.02.
EPS history for Igene Biotechnology, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -99.53% |
| 2009 | 0.00 | -99.53% |
| 2008 | $-0.02 | 23.12% |
| 2007 | $-0.02 | 61.68% |
| 2006 | $-0.01 | -55.97% |
| 2003 | $-0.02 | -37.85% |
| 2002 | $-0.04 | -19.21% |
| 2001 | $-0.05 | 20.40% |
| 2000 | $-0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $4.53 | -302,100.00% |
CA
|
|
| $14.21 | -947,433.33% |
US
|
|
| $0.36 | -24,400.00% |
CN
|
|
| $0.69 | -46,106.67% |
CN
|
|
| $1.72 | -115,013.33% |
SA
|
Questions about Igene Biotechnology, Inc.'s earnings per share (EPS)
What is Igene Biotechnology, Inc.'s earnings per share (EPS)?
Igene Biotechnology, Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Sep 2010.
What was Igene Biotechnology, Inc.'s earnings per share (EPS) in 2009?
In 2009, Igene Biotechnology, Inc.'s earnings per share (EPS) was 0.00, compared with $-0.02 in 2008.
How has Igene Biotechnology, Inc.'s earnings per share (EPS) changed since 2006?
From 2006 to 2009, Igene Biotechnology, Inc.'s earnings per share (EPS) was highest in 2009 (0.00) and lowest in 2008 ($-0.02).
How does Igene Biotechnology, Inc.'s earnings per share (EPS) compare with similar companies?
Igene Biotechnology, Inc.'s earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is CF Industries Holdings, Inc., with $14.21.